EGFR and ovarian carcinoma: There is abundant evidence that EGFR activation drives cellular processes linked to ovarian epithelial tumor development, tumor cell survival and metastasis; and clinical trials are ongoing to target ErbB family receptors for epithelial ovarian cancer therapy [27], [28].